Lab
Medical Diagnostic Laboratory LLC
Medical Diagnostic Laboratory LLC was paid $12.00M by Medicaid between Jan 2018 and Mar 2024, across 150 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 24% of everything it billed.
33Billing provider infoMEDICAL DIAGNOSTIC LABORATORY LLC
LA VERNE, CA 91750
LA VERNE, CA 91750
33aNPI1023253556assigned 12/12/2008
33bProvider typeClinical Medical Laboratory
28Total paid$12.00M
24GClaims700,472
24DCodes billed150
24AFirst – last monthJan 2018 – Mar 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#61 of 561
Median peer was paid$222K
This provider vs. median54×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 184,080 | $2.57M | |
| 2019 | 83,841 | $1.11M | |
| 2020 | 68,856 | $1.49M | |
| 2021 | 97,161 | $2.31M | |
| 2022 | 101,852 | $2.54M | |
| 2023 | 133,791 | $1.66M | |
| 2024incomplete | 30,891 | $318K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 24% | 42,319 | 24,846 | $2.90M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 12% | 48,912 | 47,271 | $1.43M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 12% | 48,751 | 47,118 | $1.43M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.7% | 35,982 | 21,478 | $685K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 5.5% | 33,686 | 32,700 | $657K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.5% | 8,857 | 8,199 | $425K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3.3% | 2,404 | 2,198 | $396K |
| 80061 | Lipid panel | 2.5% | 34,439 | 33,492 | $296K |
| 88142 | 2.3% | 15,761 | 15,314 | $272K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.1% | 14,509 | 14,014 | $254K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.0% | 23,583 | 22,700 | $245K |
| 80053 | Comprehensive metabolic panel | 2.0% | 36,607 | 34,642 | $243K |
138 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 46,272 | $233K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.8% | 658 | $219K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.8% | 31,665 | $210K |
| 80055 | 1.6% | 5,790 | $187K | |
| 86592 | 1.2% | 39,707 | $146K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 10,345 | $116K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 3,370 | $99K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 969 | $73K |
| 84702 | <1% | 5,817 | $69K | |
| 81001 | <1% | 19,724 | $58K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,400 | $57K |
| 84153 | <1% | 5,500 | $56K | |
| 87077 | <1% | 7,150 | $53K | |
| 84439 | <1% | 8,682 | $52K | |
| 84436 | <1% | 7,845 | $48K | |
| 86481 | <1% | 798 | $47K | |
| 87186 | <1% | 5,373 | $44K | |
| 80074 | <1% | 1,211 | $36K | |
| 82746 | <1% | 3,983 | $34K | |
| 84480 | <1% | 3,059 | $30K | |
| 86038 | <1% | 2,997 | $24K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 680 | $24K |
| 80050 | General health panel | <1% | 2,329 | $24K |
| 86803 | <1% | 2,082 | $22K | |
| 82043 | <1% | 6,569 | $22K | |
| 86762 | <1% | 1,944 | $22K | |
| 82951 | <1% | 2,101 | $21K | |
| 87631 | <1% | 401 | $21K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 498 | $20K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 315 | $20K |
| 86376 | <1% | 1,624 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,084 | $20K |
| 87653 | <1% | 951 | $19K | |
| 86635 | <1% | 990 | $19K | |
| 87481 | <1% | 744 | $19K | |
| 86706 | <1% | 2,322 | $19K | |
| 84403 | <1% | 908 | $18K | |
| 83735 | <1% | 3,894 | $17K | |
| 87340 | <1% | 2,146 | $17K | |
| 84550 | <1% | 6,896 | $17K | |
| 87500 | <1% | 700 | $16K | |
| 84479 | <1% | 3,732 | $16K | |
| 87640 | <1% | 687 | $16K | |
| 87486 | <1% | 628 | $16K | |
| 82570 | <1% | 5,566 | $16K | |
| 82607 | <1% | 3,930 | $16K | |
| 80076 | <1% | 3,007 | $14K | |
| 82950 | <1% | 3,839 | $14K | |
| 82728 | <1% | 1,736 | $14K | |
| 86431 | <1% | 3,630 | $14K | |
| 87498 | <1% | 465 | $14K | |
| 87581 | <1% | 573 | $14K | |
| 87081 | <1% | 2,621 | $13K | |
| 86780 | <1% | 1,258 | $13K | |
| 84681 | <1% | 752 | $13K | |
| 83540 | <1% | 3,465 | $13K | |
| 83550 | <1% | 2,491 | $13K | |
| 87505 | <1% | 278 | $12K | |
| 84270 | <1% | 652 | $11K | |
| 85651 | <1% | 5,058 | $10K | |
| 86696 | <1% | 610 | $10K | |
| 85730 | <1% | 2,381 | $10K | |
| 86141 | <1% | 1,173 | $10K | |
| 80164 | <1% | 1,032 | $10K | |
| 84481 | <1% | 940 | $9K | |
| 87634 | <1% | 164 | $8K | |
| 86235 | <1% | 70 | $8K | |
| 87070 | <1% | 1,207 | $8K | |
| 85610 | <1% | 3,357 | $8K | |
| 82378 | <1% | 1,030 | $7K | |
| 87184 | <1% | 1,785 | $7K | |
| 86140 | <1% | 1,833 | $7K | |
| 86695 | <1% | 606 | $7K | |
| 82947 | <1% | 2,292 | $7K | |
| 83880 | <1% | 1,084 | $6K | |
| 87536 | <1% | 88 | $6K | |
| 86677 | <1% | 505 | $6K | |
| 86301 | <1% | 470 | $6K | |
| 86703 | <1% | 470 | $6K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 2,829 | $5K |
| 87210 | <1% | 1,272 | $4K | |
| 85044 | <1% | 1,808 | $4K | |
| 84144 | <1% | 219 | $4K | |
| 86060 | <1% | 613 | $3K | |
| 86708 | <1% | 505 | $3K | |
| 83525 | <1% | 344 | $3K | |
| 84100 | <1% | 977 | $3K | |
| 86480 | <1% | 68 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,367 | $3K |
| 88312 | <1% | 313 | $3K | |
| 86171 | <1% | 269 | $2K | |
| 82670 | <1% | 92 | $2K | |
| 86704 | <1% | 361 | $2K | |
| 82977 | <1% | 481 | $2K | |
| 88313 | <1% | 313 | $2K | |
| 86901 | <1% | 716 | $2K | |
| 83690 | <1% | 595 | $2K | |
| 86850 | <1% | 674 | $1K | |
| 86900 | <1% | 651 | $1K | |
| 86787 | <1% | 128 | $1K | |
| 82150 | <1% | 311 | $1K | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 663 | $1K |
| 83655 | <1% | 108 | $1K | |
| 86735 | <1% | 103 | $1K | |
| 82272 | <1% | 439 | $1K | |
| 86225 | <1% | 105 | $1K | |
| 86765 | <1% | 102 | $1K | |
| 82270 | <1% | 441 | $1K | |
| 82465 | <1% | 218 | $710.80 | |
| 87541 | <1% | 24 | $673.68 | |
| 81025 | <1% | 227 | $627.62 | |
| 83970 | <1% | 24 | $618.82 | |
| 86694 | <1% | 64 | $617.36 | |
| 84146 | <1% | 80 | $560.53 | |
| 86331 | <1% | 93 | $548.70 | |
| 82248 | <1% | 269 | $459.54 | |
| 85018 | <1% | 195 | $397.56 | |
| 85014 | <1% | 176 | $372.07 | |
| 82105 | <1% | 159 | $355.97 | |
| 86304 | <1% | 53 | $271.53 | |
| 82040 | <1% | 74 | $260.67 | |
| 83002 | <1% | 25 | $250.77 | |
| 82952 | <1% | 78 | $245.70 | |
| 86689 | <1% | 14 | $242.21 | |
| 86800 | <1% | 17 | $227.24 | |
| 82785 | <1% | 15 | $220.53 | |
| 83001 | <1% | 13 | $195.96 | |
| 84703 | <1% | 23 | $142.12 | |
| 80156 | <1% | 13 | $125.78 | |
| 85027 | <1% | 20 | $113.00 | |
| 82550 | <1% | 52 | $100.47 | |
| 84156 | <1% | 29 | $87.45 | |
| 86200 | <1% | 12 | $70.93 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 235 | $61.08 |
| P9011 | Blood, split unit | <1% | 26 | $60.34 |
| 83615 | <1% | 211 | $20.22 | |
| 83090 | 0% | 214 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 184 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMENDEZ, FAUSTO (MANAGING MEMBER)
| Provider | Location | Paid |
|---|---|---|
| Advanced Medical Xray INC | La Verne, CA | $64K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.